Cellectis S.A. (EPA:ALCLS)
3.225
-0.085 (-2.57%)
Mar 6, 2026, 2:54 PM CET
Cellectis Market Cap
Cellectis has a market cap or net worth of €239.40 million as of March 6, 2026. Its market cap has increased by 129.45% in one year.
Market Cap
239.40M
Enterprise Value
270.60M
Revenue
70.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.23
Market Cap Chart
Since February 7, 2007, Cellectis's market cap has increased from 100.59M to 239.40M, an increase of 137.98%. That is a compound annual growth rate of 4.65%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Transgene | 245.35M |
| Genfit | 442.68M |
| Innate Pharma | 134.59M |
| MaaT Pharma | 133.98M |
| Adocia | 130.10M |
| Sensorion | 119.54M |
| ABIONYX Pharma | 118.89M |
| OSE Immunotherapeutics | 95.29M |